1
|
Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia.
|
Cytotherapy
|
2013
|
1.48
|
2
|
A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells.
|
J Biol Chem
|
2002
|
1.37
|
3
|
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
|
J Hematol Oncol
|
2013
|
1.29
|
4
|
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.
|
J Hematol Oncol
|
2012
|
1.02
|
5
|
Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.
|
J Transl Med
|
2011
|
0.91
|
6
|
Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.
|
Transplantation
|
2013
|
0.85
|
7
|
Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
|
Cell Transplant
|
2014
|
0.81
|
8
|
Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
|
J Hematol Oncol
|
2011
|
0.80
|
9
|
Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease.
|
DNA Cell Biol
|
2014
|
0.80
|
10
|
Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versus-host disease.
|
Acta Haematol
|
2013
|
0.79
|
11
|
Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire.
|
Immunobiology
|
2012
|
0.78
|
12
|
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation.
|
PLoS One
|
2013
|
0.76
|
13
|
Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.
|
PLoS One
|
2013
|
0.75
|
14
|
[Effects of surgical resection of pulmonary lesions to the relapse of pulmonary aspergillosis in allogeneic hematopoietic stem cell transplant recipients with invasive pulmonary aspergillosis].
|
Zhonghua Nei Ke Za Zhi
|
2016
|
0.75
|
15
|
[Analysis of infection-related mortality after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapse acute leukemia].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2012
|
0.75
|
16
|
Study of focal shift effect in planar GaN high contrast grating lenses.
|
Opt Express
|
2015
|
0.75
|
17
|
[Long-term outcomes of nilotinib treatment for chronic myelogenous leukemia patients with imatinib resistance or intolerance].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2012
|
0.75
|
18
|
Angle- and polarization-dependent spectral characteristics of circular grating filters.
|
Opt Express
|
2016
|
0.75
|
19
|
[Sorafenib as salvage therapy in refractory relapsed acute myeloid leukemia with positive FLT3 mutation].
|
Zhonghua Xue Ye Xue Za Zhi
|
2016
|
0.75
|
20
|
[Value of C-reactive protein level on transplantation day in predicting early post-transplant infections and outcomes of allogeneic?hematopoietic?stem?cell?transplantation].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2015
|
0.75
|